Researcher
Christopher Lord
Institute of Cancer Research
Statistics
228 papers found
All papers authored by Christopher Lord
Refreshing results…
,
Lauren I. Aronson ,
Dragomir B. Krastev ,
Jadwiga Nieminuszczy ,
John Alexander ,
Feifei Song ,
Malgorzata Dylewska ,
Ronan Broderick ,
Rachel Brough ,
Astrid Zimmermann ,
Frank T. Zenke ,
Bora Gurel ,
Ruth Riisnaes ,
Ana Ferreira ,
Theodoros Roumeliotis
and 8 other authors
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Upload
,
Nuria Porta,
Sara Arce-Gallego,
George Seed,
Alba Llop-Guevara,
Diletta Bianchini,
Pasquale Rescigno,
Alec Paschalis,
Claudia Bertan,
Chloe Baker,
Jane Goodall,
Susana Miranda ,
Ruth Riisnaes,
Ines Figueiredo,
Ana Ferreira
and 12 other authors
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
Download from aacrjournals.org
,
Jessica R. Frankum,
Marco Punta,
Stefano Lise ,
John Alexander ,
Yi Chen,
Timothy A. Yap ,
Syed Haider,
Andrew N. J. Tutt,
Christopher J. Lord
Upload
,
Julien Adam,
Daphné Morel ,
Marlène Garrido ,
Andrew Lamb,
Clémence Hénon,
Nicolas Dorvault,
Mathieu Rouanne ,
Rebecca Marlow ,
Ilirjana Bajrami,
Marta Llorca Cardeñosa,
Asha Konde,
Benjamin Besse
and 8 other authors
PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
Download from doi.org
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
Download from doi.org
,
Ilirjana Bajrami,
Christopher J. Lord
Synthetic Lethality and Cancer – Penetrance as the Major Barrier
Upload
The shieldin complex mediates 53BP1-dependent DNA repair
Upload
,
Ilirjana Bajrami,
James Campbell,
Irene Y. Chong,
Sara Costa-Cabral,
Richard Elliott,
Tim Fenton ,
Jessica Frankum,
Samuel E. Jones,
Malini Menon,
Rowan Miller,
Helen N. Pemberton
and 14 other authors
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
Download from www.nature.com
,
Susana Banerjee,
Rachael Natrajan
Download from doi.org
Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?
Upload
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer
Download from cancerdiscovery.aacrjournals.org
,
Marlène Garrido ,
Daphné Morel ,
Dragomir B. Krastev,
Ludovic Bigot,
Julien Adam,
Jessica R. Frankum,
Sylvère Durand,
Clement Pontoizeau,
Sylvie Souquère,
Mei-Shiue Kuo,
Sylvie Sauvaigo
and 11 other authors
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Download from doi.org
Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in Breast Cancer
Download from aacrjournals.org
PARP inhibitors and breast cancer: highlights and hang-ups
Upload
Identifying Genetic Dependencies in Cancer by Analyzing siRNA Screens in Tumor Cell Line Panels
Download from link.springer.com
,
Frances Daley,
Syed Haider,
Divya Kriplani,
James Campbell,
Hasan Mirza,
Anita Grigoriadis,
Andrew Tutt,
Paul M. Moseley,
Tarek M. A. Abdel-Fatah,
Stephen Y. T. Chan,
Srinivasan Madhusudan,
Emad A. Rhaka
and 5 other authors
Download from mct.aacrjournals.org
Missing publications? Search for publications with a matching author name.